Cargando…
Pharmacokinetic considerations to optimize clinical outcomes for COVID-19 drugs
The development of clinically effective drugs that could complement existing vaccines is urgently needed to reduce the morbidity and mortality associated with COVID-19. Drug-metabolizing enzymes, membrane-associated drug transporters, and inflammatory responses can partly determine the safety and ef...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Ltd.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9510059/ https://www.ncbi.nlm.nih.gov/pubmed/36374805 http://dx.doi.org/10.1016/j.tips.2022.09.005 |